Month: March 2025
Excerpt from the Press Release: SAN DIEGO, Feb. 19, 2025 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today that the first patient has been dosed in the clinical study of peluntamig (PT217) in combination with chemotherapy. Peluntamig (PT217), a first-in-class native…
Read More
In the complex world of pharmaceutical clinical trials, efficiency, accuracy, and real-time data access are paramount. Systems integration plays a crucial role in ensuring these elements are met, significantly improving the trial process. By integrating multiple technology systems-such as Electronic Data Capture (EDC), clinical trial management systems (CTMS), and imaging platforms-trial teams can create a…
Read More
Excerpt from the Press Release: BOSTON & SHENZHEN, China–(BUSINESS WIRE)–Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for SIGX1094, the world’s first potential targeted therapy for diffuse gastric cancer (DGC). This designation is designed to accelerate…
Read More- « Previous
- 1
- 2
- 3